Free Trial

Calidi Biotherapeutics (CLDI) Earnings Date, Estimates & Call Transcripts

$0.30
+0.05 (+17.65%)
(As of 05/30/2024 09:03 PM ET)

Earnings Summary

Latest
Earnings Date
May. 14Estimated
Actual EPS
(May. 14)
-$0.20 Beat By $0.07
Consensus EPS
(May. 14)
-$0.27
Skip Charts & View Estimated and Actual Earnings Data

CLDI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLDI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Calidi Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.27)($0.27)($0.27)
Q2 20241($0.25)($0.25)($0.25)
Q3 20241($0.21)($0.21)($0.21)
Q4 20241($0.18)($0.18)($0.18)
FY 20244($0.91)($0.91)($0.91)

CLDI Earnings Date and Information

Calidi Biotherapeutics last released its quarterly earnings results on May 14th, 2024. The reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.07. Calidi Biotherapeutics has generated $0.00 earnings per share over the last year.

Calidi Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024Q1 2024($0.27)($0.20)+$0.07($0.20)--
11/14/2023Q3 2023-($0.14)($0.14)($0.14)--

Calidi Biotherapeutics Earnings - Frequently Asked Questions

When did Calidi Biotherapeutics announce their last quarterly earnings?

Calidi Biotherapeutics (NYSEAMERICAN:CLDI) last announced its quarterly earning data on Tuesday, May 14, 2024. Learn more on CLDI's earnings history.

Did Calidi Biotherapeutics beat their earnings estimates last quarter?

In the previous quarter, Calidi Biotherapeutics (NYSEAMERICAN:CLDI) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.07. Learn more on analysts' earnings estimate vs. CLDI's actual earnings.

How much revenue does Calidi Biotherapeutics generate each year?

Calidi Biotherapeutics (NYSEAMERICAN:CLDI) has a recorded annual revenue of $50,000.00.

How much profit does Calidi Biotherapeutics generate each year?

Calidi Biotherapeutics (NYSEAMERICAN:CLDI) has a recorded net income of -$29.22 million. CLDI has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NYSEAMERICAN:CLDI) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners